Pathogenesis and Prevention. Philadelphia, PA: The Franklin Institute Press; 1978. 5. Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients—California, Nebraska, and Texas. MMWR 1996;45:285-289. 6. Garner JS, the Hospital Infection Control Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80. 7. Alter MJ, Ahtone J, Maynard JE. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983;99:330-333. 8. Carl M, Francis DP Maynard JE. A common-source outbreak of hepatitis B in a hemodialysis unit Dialysis and Transplantation 1983;12:222-229. 9. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;1:550-551. 10. Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, et al. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II, haemodialysis patients. Lancet 1981;1:797-800. 11. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984;311:496-501. 12. Alter MJ, Favero MS, Francis DP. Cost benefit of vaccination for hepatitis B in hemodialysis centers. / Infect Dis 1983;148:770-771. 13. Centers for Disease Control. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR 1982;31:317-322,327,328.
[1]
W. Szmuness,et al.
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
,
1984,
The New England journal of medicine.
[2]
B. Simmons,et al.
Guideline for isolation precautions in hospitals
,
1984,
American Journal of Infection Control.
[3]
M. Alter,et al.
Cost benefit of vaccination for hepatitis B in hemodialysis centers.
,
1983,
The Journal of infectious diseases.
[4]
M. Alter,et al.
Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit.
,
1983,
Annals of internal medicine.
[5]
P. Jungers,et al.
RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTS
,
1981,
The Lancet.
[6]
M. Favero,et al.
SURVIVAL OF HEPATITIS B VIRUS AFTER DRYING AND STORAGE FOR ONE WEEK
,
1981,
The Lancet.